Utama › Kanser Pankreas › Nebraska › Omaha
Kajian klinikal Kanser Pankreas di Omaha, NE
14 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi dalam dan sekitar Omaha (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- Nebraska Cancer Specialists, Omaha
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Mengambil pesertaFasa 2/3
- Nebraska Medicine, Omaha
- Nebraska Medicine - Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Mengambil pesertaFasa 3
- University of Nebraska Medical Center, Omaha
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Mengambil pesertaFasa 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Mengambil pesertaKajian pemerhatian
- University of Nebraska Medical Center, Omaha
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Mengambil pesertaFasa 3
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
Pancreatic Cancer Early Detection Consortium
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of Nebraska Medical Center, Omaha
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Mengambil pesertaFasa 2
- Nebraska Cancer Specialists, Omaha
Integrated Cancer Repository for Cancer Research
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- dan 1 lagi
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Mengambil pesertaFasa 1
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 247399, Omaha
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Mengambil pesertaFasa 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- dan 1 lagi
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Nebraska Cancer Specialists, Omaha
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Mengambil pesertaFasa 2
- Ohio State University-Telemedicine, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Omaha
Kajian Kanser Pankreas di bandar lain
- Houston, TX61 kajian
- New York City, NY60 kajian
- Boston, MA43 kajian
- Nashville, TN39 kajian
- Los Angeles, CA35 kajian
- St. Louis, MO33 kajian
- Arlington, VA33 kajian
- Baltimore, MD31 kajian
- San Antonio, TX31 kajian
- Philadelphia, PA26 kajian
- Tampa, FL26 kajian
- Durham, NC24 kajian
Kajian lain di Omaha
- Kanser Prostat27 kajian
- Kanser Paru-paru Bukan Sel Kecil24 kajian
- Kanser Payudara22 kajian
- Kanser (semua jenis)18 kajian
- Kanser Kolorektal18 kajian
- Mieloma Pelbagai16 kajian
- Kanser Ovari14 kajian
- Limfoma Bukan Hodgkin14 kajian
- Kanser Metastatik13 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher13 kajian
- Kegagalan Jantung13 kajian
- Melanoma12 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.